Purchase Order 75F40124P00011
Award Date 12/12/23
Potential Completion Date 12/11/28
Potential Value $97K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30309, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $54,160.60 firm fixed price purchase order to Life Technologies Corporation of Atlanta, GA for 7500 FAST real-time PCR systems (polymerase chain reaction), serial number 275015685. The period of performance is through March 31, 2027. No set-aside designation was used for this procurement of laboratory equipment, which will support the FDA's work to evaluate nucleic acid-based diagnostic tests and tests. Life...
- The U.S. Food and Drug Administration (FDA) awarded a $87,843.87 firm-fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, to provide preventative and corrective maintenance services for 7,500 real-time PCR systems over a 4-year period ending on August 31, 2025. This award was not set aside for any small business program. The original solicitation, FDA_21-223-1236746, was posted on November 10, 2020 with a due date of...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables that provides a wide range of products and services to support biomedical research, applied markets, and forensic analysis for the federal government. The contract, valued at $16,708.68, is for a maintenance agreement for a Life Technologies ViiA(TM) real-time PCR system. The contract has an...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of a genetic analyzer with a 4-year post-warranty maintenance option, with a ceiling value of $80,335.95 and a completion date of September 14, 2025. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $12,480.00, is for the maintenance of SANFL AB 7500 equipment. The award has no set-aside designation. Life Technologies Corporation is a prime contractor that serves the FDA, as well as other federal agencies like the National Institutes of Health, Department of Defense,...
- This is a $73,004.64 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation for preventative maintenance service. The contract has no set-aside designation. Life Technologies Corporation is a manufacturer of scientific instruments, reagents, and consumables that provides products and services to support various federal agencies including the NIH, DOD, USDA, DOC, and DOJ. The contract is likely part of a larger indefinite delivery...
- This is a federal contract award from the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for $95,672.40 to provide genetic analyzer corrective/remedial repair and preventive maintenance services. The contract has a period of performance through February 9, 2022 and is a firm fixed price purchase order. There is no set-aside designation. Life Technologies has established itself as a prime contractor across multiple federal...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a firm fixed price purchase order to Life Technologies Corporation for the reinstallation of laboratory instruments at the agency's facility in Dauphin Island, Alabama. With a period of performance from June 18, 2017 through June 30, 2017, this $100,000 or less contract supports the FDA's mission to protect public health by ensuring the safety and effectiveness of medical devices through testing and...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for a MICROSEQ GENETIC ANALYZER. The $323,879.64 award does not have a set-aside designation and was made on August 24, 2017 with a completion date of August 23, 2021. As a division of Thermo Fisher Scientific, Life Technologies serves as a prime contractor across various federal...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $195,000 contract is for the upgrade of ABI software, with a completion date of September 25, 2023. Life Technologies has experience providing a range of genetic analysis and laboratory equipment products and services to support federal biomedical research, medical...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract valued at ninety-six thousand nine hundred twenty-two dollars and eighty-five cents ($96,922.85) to Life Technologies Corporation. The contract is for the purchase of assurance preventative maintenance for an Applied Biosystems 3500XL genetic analyzer located in Atlanta, Georgia, and includes reinstatement fees for the base year plus four option years. Performance will take place at the prime contractor's location in Atlanta, Georgia through December 2028. No subcontractors or set aside designations were identified. The contract supports the FDA's medical device evaluation and regulatory programs.
Generated 12/24/23, 1:10 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 12/12/23 |